statistiche ricercatore

RIVA, NICOLETTA

Distribuzione geografica

Continente	#
NA - Nord America	2.077
EU - Europa	838
AS - Asia	692
SA - Sud America	65
AF - Africa	12
OC - Oceania	4
Totale	3.688

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.052
IT - Italia	451
SG - Singapore	210
CN - Cina	163
UA - Ucraina	105
VN - Vietnam	97
TR - Turchia	95
HK - Hong Kong	84
SE - Svezia	53
BR - Brasile	52
DE - Germania	44
IE - Irlanda	40
GB - Regno Unito	36
FR - Francia	34
RU - Federazione Russa	29
CA - Canada	16
FI - Finlandia	16
BD - Bangladesh	11
MX - Messico	8
AR - Argentina	7
HR - Croazia	7
IN - India	7
PL - Polonia	6
NL - Olanda	5
PK - Pakistan	5
AU - Australia	4
AT - Austria	3
EG - Egitto	3
IQ - Iraq	3
PH - Filippine	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
CL - Cile	2
EC - Ecuador	2
JP - Giappone	2
LT - Lituania	2
MY - Malesia	2
NG - Nigeria	2
UZ - Uzbekistan	2
AL - Albania	1
BE - Belgio	1
BO - Bolivia	1
CH - Svizzera	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ES - Italia	1
ET - Etiopia	1
GR - Grecia	1
ID - Indonesia	1
IL - Israele	1
LB - Libano	1
LY - Libia	1
MA - Marocco	1
MD - Moldavia	1
OM - Oman	1
PA - Panama	1
SA - Arabia Saudita	1
TH - Thailandia	1
Totale	3.688

Salva come PNG Salva come JPEG

Città	#
Milan	329
Fairfield	236
Woodbridge	201
Ashburn	169
Ann Arbor	142
San Jose	137
Houston	134
Singapore	128
Dallas	112
Chandler	96
Cambridge	90
Wilmington	90
Jacksonville	88
Seattle	87
Hong Kong	82
The Dalles	51
Izmir	48
Beijing	40
Princeton	40
Dublin	36
Ho Chi Minh City	30
Dearborn	29
Boardman	26
Nyköping	26
Lauterbourg	22
Rome	18
Chicago	17
London	16
Los Angeles	16
Dong Ket	15
Hanoi	15
New York	12
Washington	11
Guangzhou	10
San Diego	10
Shanghai	9
Ogden	8
Como	7
Council Bluffs	7
Mexico City	7
Zagreb	7
Hefei	6
Nuremberg	6
Santa Clara	6
Tianjin	6
Warsaw	6
Boston	5
Düsseldorf	5
Montreal	5
Toronto	5
Denver	4
Frankfurt am Main	4
Norwalk	4
Shenzhen	4
Chennai	3
Dhaka	3
Haiphong	3
Hangzhou	3
Jinan	3
Nanchang	3
Nanjing	3
Orem	3
Redwood City	3
San Mateo	3
Shibin al Kawm	3
São Paulo	3
Abuja	2
Atlanta	2
Belfast	2
Berlin	2
Besana In Brianza	2
Biên Hòa	2
Campinas	2
Cavaria con Premezzo	2
Changsha	2
Columbus	2
Dalian	2
Elk Grove Village	2
Helsinki	2
Lahore	2
Martinengo	2
Naples	2
Ottawa	2
Panama City	2
Prescot	2
Quzhou	2
Quận Năm	2
San Francisco	2
Santa Fe	2
Strasbourg	2
São José do Rio Preto	2
Tashkent	2
Tokyo	2
Trecate	2
Verona	2
Addis Ababa	1
Al Hillah	1
Aldo Bonzi	1
Alvorada	1
Americana	1
Totale	2.819

Salva come PNG Salva come JPEG

Nome	#
Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes	311
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	254
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data	217
Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulants	212
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	209
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	205
Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study	204
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation	196
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	191
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	180
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.	158
Portal vein thrombosis in decompensated cirrhosis: rationale for treatment	153
Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism	152
Which patients with venous thromboembolism should receive non-vitamin k antagonist oral anticoagulants? The majority	141
Stroke: Patients with CVT urgently need high-quality evidence	123
Clinical history of cancer-associated splanchnic vein thrombosis	108
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.	94
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score	92
Recommendations from the ICM-VTE: General	85
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants	83
Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: A systematic review and meta-analysis	75
Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected pulmonary embolism: a systematic review and meta-analysis	70
The effect of DOAC-Stop® on several oral and parenteral anticoagulants	69
Mitigating Disputes Originated by Multiple Discordant Systematic Reviews and Meta-Analyses: A Survey of Methodologists and Clinicians	62
Trials of interventions for ovarian and testicular germ cell tumors registered in ClinicalTrials.gov: A cross-sectional study	49
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis	46
Totale	3.739

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	15.306
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	15.306

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	99	0	0	0	0	0	0	0	0	0	36	29	34
2021/2022	166	22	9	4	2	7	12	6	9	4	50	17	24
2022/2023	257	21	8	28	18	21	54	3	41	40	9	4	10
2023/2024	559	90	90	80	106	118	51	0	2	10	9	0	3
2024/2025	384	3	3	56	12	17	46	26	18	19	52	45	87
2025/2026	886	74	61	108	94	72	61	216	59	88	53	0	0
Totale													3.739